Long-term Outcome of High-dose Salvage Chemoradiation for Patients with Early Stage Hodgkin Lymphoma (HL) Who Failed Initial Treatment with Combined Modality Treatment (CMT) or Chemotherapy Alone (C)

Term Outcome ◽

Long Term Outcome ◽

Involved node radiation therapy in the combined modality treatment for early-stage Hodgkin lymphoma: Analysis of relapse location and long-term outcome

Radiotherapy and Oncology ◽

10.1016/j.radonc.2020.06.046 ◽

2020 ◽

Vol 150 ◽

pp. 236-244

Author(s):

Karin Nielsen ◽

Maja Vestmoe Maraldo ◽

Anne Kiil Berthelsen ◽

Annika Loft ◽

Peter de Nully Brown ◽

...

Keyword(s):

Radiation Therapy ◽

Hodgkin Lymphoma ◽

Early Stage ◽

Term Outcome ◽

Long Term Outcome ◽

Long-term Outcome of Involved Node Radiation Therapy for Early Stage Hodgkin Lymphoma

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2018.06.308 ◽

2018 ◽

Vol 102 (3) ◽

pp. S123

Author(s):

K. Nielsen ◽

M.V. Maraldo ◽

M.C. Aznar ◽

P.M. Petersen ◽

I. Vogelius ◽

...

Keyword(s):

Radiation Therapy ◽

Hodgkin Lymphoma ◽

Early Stage ◽

Term Outcome ◽

Long Term Outcome

308: An Update of Selective Bladder Preservation Using Combined Modality Treatment in Invasive Bladder Cancer: Long Term Outcome Reveals a Low Risk of Invasive Recurrence and a High Probability of Bladder Preservation

The Journal of Urology ◽

10.1016/s0022-5347(18)37570-0 ◽

2004 ◽

Vol 171 (4S) ◽

pp. 81-81 ◽

Cited By ~ 2

Author(s):

John J. Coen ◽

Niall M. Heney ◽

Alex F. Althausen ◽

Anthony L. Zietman ◽

Donald S. Kaufman ◽

...

Keyword(s):

Bladder Cancer ◽

High Probability ◽

Low Risk ◽

Invasive Bladder Cancer ◽

Bladder Preservation ◽

Term Outcome ◽

Long Term Outcome ◽

Pilot Study of Preoperative Combined Modality Treatment for Locally Advanced Operable Oesophageal Carcinoma: Toxicities and Long-term Outcome

Clinical Oncology ◽

10.1016/j.clon.2005.12.009 ◽

2006 ◽

Vol 18 (4) ◽

pp. 338-344 ◽

Cited By ~ 5

Author(s):

S. Mukherjee ◽

J. Abraham ◽

A. Brewster ◽

R. Hardwick ◽

T. Havard ◽

...

Keyword(s):

Pilot Study ◽

Locally Advanced ◽

Oesophageal Carcinoma ◽

Term Outcome ◽

Long Term Outcome ◽

Long term outcome after combined modality treatment for anal cancer

Radiology and Oncology ◽

10.2478/v10019-012-0022-2 ◽

2012 ◽

Vol 46 (2) ◽

Cited By ~ 16

Author(s):

Irena Oblak ◽

Primoz Petric ◽

Franc Anderluh ◽

Vaneja Velenik ◽

Peter Fras

Keyword(s):

Anal Cancer ◽

Term Outcome ◽

Long Term Outcome ◽

Comparison of initial characteristics and long-term outcome of patients with lymphocyte-predominant Hodgkin lymphoma and classical Hodgkin lymphoma at clinical stages IA and IIA prospectively treated by brief anthracycline-based chemotherapies plus extended high-dose irradiation

Blood ◽

10.1182/blood-2004-02-0567 ◽

2004 ◽

Vol 104 (9) ◽

pp. 2675-2681 ◽

Cited By ~ 48

Author(s):

P. Feugier

Keyword(s):

Hodgkin Lymphoma ◽

High Dose ◽

Classical Hodgkin Lymphoma ◽

Term Outcome ◽

Long Term Outcome ◽

Dose Irradiation ◽

Clinical Stages

Review for "Post‐remission Therapy with Repeated Courses of High Dose Cytarabine, Idarubicin and Limited Autologous Stem Cell Support Achieves a Very Good Long‐Term Outcome in ELN Favorable and Intermediate‐Risk AML"

10.1002/hon.2806/v1/review1 ◽

2020 ◽

Author(s):

Felicetto Ferrara

Keyword(s):

Stem Cell ◽

High Dose ◽

Intermediate Risk ◽

Term Outcome ◽

Long Term Outcome ◽

Stem Cell Support ◽

High Dose Cytarabine ◽

Cell Support

Decision letter for "Post‐remission Therapy with Repeated Courses of High Dose Cytarabine, Idarubicin and Limited Autologous Stem Cell Support Achieves a Very Good Long‐Term Outcome in ELN Favorable and Intermediate‐Risk AML"

10.1002/hon.2806/v1/decision1 ◽

2020 ◽

Keyword(s):

Stem Cell ◽

High Dose ◽

Intermediate Risk ◽

Term Outcome ◽

Long Term Outcome ◽

Stem Cell Support ◽

High Dose Cytarabine ◽

Cell Support

Long-Term Outcomes of Patients with Early-Stage Non-Bulky Hodgkin Lymphoma Treated with Combined Modality Therapy on the Stanford V Trials (The G4 and G5 Studies)

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2020.12.039 ◽

2020 ◽

Author(s):

Eric Mou ◽

Ranjana H. Advani ◽

Rie von Eyben ◽

Saul A. Rosenberg ◽

Richard T. Hoppe

Keyword(s):

Hodgkin Lymphoma ◽

Early Stage ◽

Combined Modality Therapy ◽

Long Term Outcomes ◽

Short and long-term outcome of treatment with high-dose melphalan and stem cell transplantation for multiple myeloma-associated AL amyloidosis

Annals of Hematology ◽

10.1007/s00277-009-0874-8 ◽

2009 ◽

Vol 89 (6) ◽

pp. 579-584 ◽

Cited By ~ 12

Author(s):

Saulius Girnius ◽

David C. Seldin ◽

Martha Skinner ◽

Kathleen T. Finn ◽

Karen Quillen ◽

...

Keyword(s):

Multiple Myeloma ◽

Stem Cell ◽

Stem Cell Transplantation ◽

High Dose ◽

Al Amyloidosis ◽

Term Outcome ◽

Long Term Outcome ◽

Short And Long Term ◽

High Dose Melphalan